Gradual titration helps: Reduce the risk of side effects Improve long-term tolerability Allow your body to adapt safely Support sustainable weight loss This structured increase is based on clinical research and is designed to balance safety with effectiveness
Trajectoire type : Poids dpart : 92 kg Phase 1 (12 mois Wegovy) : -16 kg 76 kg (17% perte) Arrt traitement (contrainte budgtaire) Phase 2 (12 mois post-arrt) : +10 kg 86 kg Pattern observ (donnes STEP 4 bras placebo) : Mois 1-3 post-arrt : Poids stable Mois 4-6 : Retour apptit progressif Mois 7-12 : Regain acclr (fringales, portions augmentes) Regain mdian : 62,5% du poids perdu (10 kg sur 16 kg) Leon STEP 4 : Wegovy = traitement chronique
Sequence & Structural Notes: What can be verified
This dose is not necessarily intended to cause massive weight loss right out of the gate
Lesser amounts are found in the brain and the retina
Jaclyn Leong, Medical Director of the UCI Health Weight Management Program, at the ObesityHelp 2025 National Conference, where she discussed evidence-based nutrition, resistance training, and integrative strategies to support lean body mass during GLP-1 therapy
